SEQUENOM Announces Gene Expression Agreement With the University of Tuebingen
MassARRAY(TM) Compact System Reference Site Established
"SEQUENOM's MassARRAY system offers a level of specificity, accuracy and particularly quantitative reproducibility that makes it ideally suited to clinically validate microarray-generated research data," said Olaf Riess, M.D., Director of the Institute. "Utilizing MassARRAY technology, we have the ability to achieve a high level of data quality with extremely low standard deviations across a wide range of concentrations of genetic target material in multiple clinical and transgenic samples."
The Institute will also serve as a MassARRAY Compact reference site. The Compact is a flexible benchtop system that supports all platform applications, including MassARRAY QGE, SNP Genotyping, SNP Discovery, Allele Frequency Analysis and Long-Range Haplotyping.
"We are pleased that the Institute has recognized the MassARRAY system's ability to deliver outstanding data quality and reproducibility in gene expression and has chosen our technology for its clinical validation needs," said Toni Schuh, Ph.D., SEQUENOM's President and Chief Executive Officer. "We believe that the system's performance characteristics will redefine quality benchmarks in the growing market of quantitative genetic analysis, and we see this as an area of strong future growth for SEQUENOM."
Topics
Organizations
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.